NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 305 filers reported holding NOVOCURE LTD in Q3 2022. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,023,280 | -88.6% | 63,361 | -70.7% | 0.00% | -88.9% |
| Q2 2023 | $8,988,984 | +829.2% | 216,602 | +1246.5% | 0.02% | +800.0% |
| Q1 2023 | $967,412 | -86.7% | 16,086 | -84.6% | 0.00% | -86.7% |
| Q2 2022 | $7,282,000 | +2617.2% | 104,760 | +2832.8% | 0.02% | – |
| Q4 2021 | $268,000 | -47.6% | 3,572 | +21.0% | 0.00% | -100.0% |
| Q4 2020 | $511,000 | +41.9% | 2,951 | -82.1% | 0.00% | -80.0% |
| Q1 2018 | $360,000 | – | 16,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |